Umbrex is pleased to welcome Simon Pannatier. Simon has a track record in leading strategic projects and teams, and implementing business change transformation. As a Senior Strategy Consultant, he has delivered shareholder value for Fortune 500 in South-East Asia and Europe for over six years (BCG, independent consultant). Before BCG, Simon held managing positions at Roche, and PEG Africa (renewable energy scale up) where he spearheaded commercial operations in West Africa and Switzerland. He started his career at Procter &…

Umbrex is pleased to welcome Frank Deane with Lumleian. Frank describes his practice : I am a former Bain Consultant with significant experience in strategic planning and portfolio analysis for Life Sciences companies and Life Sciences investors. Having begun my career at Eli Lilly evaluating pipeline assets and supporting portfolio optimization, forecasting, and business unit strategic planning, I bring a deep knowledge of the Life Sciences space. I also worked as a consultant with Leerink Swann focused on the Life…

Kian Beyzavi shares a post that takes a look at the driving factors behind innovation in Life Sciences.  The healthcare industry is changing worldwide.  The key trends contributing to this change stem from evolving behaviors and needs of the key stakeholders: Patient, Providers, Payors/Employers as well as emerging technologies: Patients are empowered, educated and tech savvy.  They increasingly demand the same user experience in managing their disease as they receive in other parts of their lives such as banking or…

Umbrex is pleased to welcome Ana Maricevic with Partners for Life. Ana is a research immunologist by training and still fascinated by all things medical. She started out at McKinsey and moved on to be an independent consultant, investor and board director in Life Science companies. She has expertise in innovation, new business development and oncology among others. Having recently arrived in Boston she is looking forward to potential collaboration….